Alison Mungenast, PhD
About Alison Mungenast, PhD
Alison Mungenast, PhD, serves as the Senior Director of CNS Biology and has held various leadership roles in neuroscience research. Her extensive experience includes positions at notable institutions such as Sana Biotechnology, Eisai US, and the University of Pennsylvania, where she has focused on innovative approaches in neurological disease research.
Work at Sana Biotechnology
Alison Mungenast served as the Senior Director of CNS Biology at Sana Biotechnology, Inc. for a period of seven months in 2022. Her role was based in Cambridge, Massachusetts, where she focused on advancing research and development in the field of central nervous system (CNS) biology. Prior to this position, she held the role of Director of CNS Cell Therapy at the same organization from 2021 to 2022, contributing to the development of innovative therapies targeting neurological diseases.
Education and Expertise
Alison Mungenast holds a Bachelor's Degree with Honors in Psychology from Cornell University. She furthered her education at Oregon Health & Science University, where she earned a PhD in Neuroscience. Her academic background is complemented by studies in Psychology at Universidad de Sevilla. Mungenast possesses expertise in genome editing and cell therapy, showcasing her strong foundation in advanced biotechnological techniques.
Background in Neuroscience Research
Mungenast has a diverse background in neuroscience research, having worked in various capacities across multiple institutions. She was a Postdoctoral Fellow at the University of Pennsylvania from 2005 to 2009. Prior to that, she spent six years as a Research Manager at the Massachusetts Institute of Technology from 2010 to 2016. Her early research experience includes roles as an Undergraduate Research Assistant at Cornell University and as a Research Laboratory Technician at Harvard University.
Professional Experience at Eisai US
Alison Mungenast held multiple positions at Eisai US, where she contributed significantly to neuroscience research. She worked as a Principal Scientist and Neuroscience Lead from 2019 to 2021, and prior to that, she was a Senior Scientist in Functional Neurogenomics from 2018 to 2019. Her experience also includes a role as a Scientist focusing on Target Validation in Functional Neurogenomics from 2016 to 2018. This extensive experience has equipped her with skills in both in vivo and in vitro assay development.
Commitment to Advancing Neuroscience
Alison Mungenast actively seeks leadership roles that leverage her creativity and experience to innovate in the field of neurological disease research. She demonstrates a strong focus on accelerating pre-clinical programs using novel approaches, reflecting her commitment to advancing the field of neuroscience. Her extensive experience in assay development and her expertise in cutting-edge techniques position her as a key contributor to advancements in neurological therapies.